1. Letter in Response to ‘Approach to Oligometastatic Cancer in the Elderly Patient’

   • Fergus Macbeth
   • Tom Treasure
   • Norman R. Williams

   Letter to the Editor 22 April 2022 Pages: 1091 - 1093

   

2. Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review

   • Caroline Plazy
   • Dalil Hannani
   • Elisa Gobbini

   Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 07 April 2022 Pages: 1095 - 1106

   

3. Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer

   • Vaia Florou
   • Ignacio Garrido-Laguna

   Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 12 April 2022 Pages: 1107 - 1112

   

4. Quality of Life and Survivorship in Lymphoma

   • Allison Rosenthal

   Lymphomas (T Hilal, Section Editor) 08 April 2022 Pages: 1113 - 1120

5. Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies

   • Michael R. Cook
   • Kieron Dunleavy

   Lymphomas (T Hilal, Section Editor) 11 April 2022 Pages: 1121 - 1131

   

6. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances

   • Jérôme Paillassa
   • Elsa Maitre
   • Xavier Troussard

   Lymphomas (T Hilal, Section Editor) 11 April 2022 Pages: 1133 - 1143

   

7. Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers

   • Albert Y. Han
   • Maie A. St. John

   Head and Neck Cancers (EY Hanna, Section Editor) Open access 08 April 2022 Pages: 1145 - 1152

   

8. Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity

   • Manisha Salinas
   • Ashish Chintakuntlawar
   • Katharine A. R. Price

   Head and Neck Cancers (EY Hanna, Section Editor) Open access 14 April 2022 Pages: 1153 - 1161

9. Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health—a Scoping Review

   • Monica Pinto
   • Dario Calafiore
   • Alessandro de Sire

   Cancer Rehabilitation (S Shahpar, Section Editor) Open access 11 April 2022 Pages: 1163 - 1175

   

10. Enhanced Recovery After Surgery (ERAS) in Surgical Oncology

    • Javier Ripollés-Melchor
    • Ane Abad-Motos
    • Andrés Zorrilla-Vaca

    Anesthesiology and Critical Care (JP Cata, Section Editor) 11 April 2022 Pages: 1177 - 1187

    

11. CAR T-Cell Therapy in the Older Person: Indications and Risks

    • Geoffrey Shouse
    • Alexey V. Danilov
    • Andy Artz

    Geriatric Oncology (L Balducci, Section Editor) 14 April 2022 Pages: 1189 - 1199

    

12. Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022

    • Benjamin L. Maughan

    Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) Open access 19 April 2022 Pages: 1201 - 1208

    

13. Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy

    • Peng V. Wu
    • Arun Rangaswami

    Pediatric Oncology (KL Davis, Section Editor) 19 April 2022 Pages: 1209 - 1218